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Abstract
Background: To evaluate the performance of surface-based deformable image registration (DR)
for adaptive radiotherapy of non-small cell lung cancer (NSCLC).
Methods: Based on 13 patients with locally advanced NSCLC, CT images acquired at treatment
planning, midway and the end of the radio- (n = 1) or radiochemotherapy (n = 12) course were
used for evaluation of DR. All CT images were manually [gross tumor volume (GTV)] and
automatically [organs-at-risk (OAR) lung, spinal cord, vertebral spine, trachea, aorta, outline]
segmented. Contours were transformed into 3D meshes using the Pinnacle treatment planning
system and corresponding mesh points defined control points for DR with interpolation within the
structures. Using these deformation maps, follow-up CT images were transformed into the
planning images and compared with the original planning CT images.
Results: A progressive tumor shrinkage was observed with median GTV volumes of 170 cm3
(range 42 cm3 - 353 cm3), 124 cm3 (19 cm3 - 325 cm3) and 100 cm3 (10 cm3 - 270 cm3) at treatment
planning, mid-way and at the end of treatment. Without DR, correlation coefficients (CC) were
0.76 ± 0.11 and 0.74 ± 0.10 for comparison of the planning CT and the CT images acquired mid-
way and at the end of treatment, respectively; DR significantly improved the CC to 0.88 ± 0.03 and
0.86 ± 0.05 (p = 0.001), respectively. With manual landmark registration as reference, DR reduced
uncertainties on the GTV surface from 11.8 mm ± 5.1 mm to 2.9 mm ± 1.2 mm. Regarding the
carina and intrapulmonary vessel bifurcations, DR reduced uncertainties by about 40% with residual
errors of 4 mm to 6 mm on average. Severe deformation artefacts were observed in patients with
resolving atelectasis and pleural effusion, in one patient, where the tumor was located around large
bronchi and separate segmentation of the GTV and OARs was not possible, and in one patient,
where no clear shrinkage but more a decay of the tumor was observed.
Discussion: The surface-based DR performed accurately for the majority of the patients with
locally advanced NSCLC. However, morphological response patterns were identified, where
results of the surface-based DR are uncertain.
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Background
Traditionally, radiotherapy was characterized by a unidi-
rectional work-flow: planning images were acquired prior
to treatment, these images were the basis for generation of
radiotherapy treatment plans and these plans were deliv-
ered throughout the total course of radiotherapy. For cer-
tain indications, a shrinking field approach was practiced
but delineation of the boost target volume was still per-
formed in the primary planning image.
Recently, volume imaging became available for in-room
image guidance aiming at verification of the target posi-
tion prior to treatment. Techniques like in-room CT scan-
ner [1], cone-beam CT (both kilovoltage [2] and
megavoltage [3] cone beam CT) and the tomotherapy sys-
tem [4] offer sufficient soft tissue contrast for position ver-
ification of soft tissue tumors. Studies using these imaging
technologies clearly showed that the planning CT image
needs to be considered as a snapshot of the patients' anat-
omy, which may or may not be representative for the
course of fractionated radiotherapy. For pulmonary
tumors, base-line drifts independently from the bony
anatomy have been reported [5-7], which may decrease
target coverage and increase doses to organs-at-risk (OAR)
if not corrected by means of image guidance.
Analysis of these verification images acquired during radi-
otherapy showed not only changes of the target position
but also more complex changes like weight loss of the
patients during treatment, changes of pulmonary atelecta-
sis and pleural effusion and tumor shrinkage. Barker et al.
reported regression of irradiated head and neck tumors by
70% during the treatment course and this tumor shrink-
age was associated with changes of the spatial relationship
between the target and the parotid glands [8]. Similar
findings were made for non-small-cell lung cancer
(NSCLC), where a continuous tumor regression during
radiotherapy was observed [9].
This continuous tumor regression during radiotherapy
makes adaptive radiotherapy (ART) approaches highly
attractive: adaptive radiation therapy is defined as a
closed-loop, iterative process where the treatment plan is
modified based on feedback measurements performed
during treatment [10]. Such concepts aim at improved
accuracy of treatment allowing either an escalation of the
irradiation dose or reduction of doses to OAR e.g. by
shrinking the radiation fields corresponding to target
shrinkage. Additionally, adaptation of the treatment plan
to tumor progression or systematic target displacements
during treatment are expected to improve target coverage.
If multiple plans are delivered during the course of treat-
ment, calculation of composite dose distributions is
required for inclusion of this information into the feed-
back loop of ART and for final analysis of the delivered
dose distribution. In the absence of morphological
changes, time weighted summation of these dose distribu-
tions is quite straight forward. However, if ART is based on
images with significant morphological changes of the
patients' anatomy, deformable image registration is
required for tracking of each anatomical structure, of all
corresponding voxels. The vectors between corresponding
voxels define deformation maps, which are finally applied
to the corresponding dose distributions and allow for
their summation. Consequently, deformable image regis-
tration (DR) is an essential part of all ART protocols,
where morphological changes may be present. Addition-
ally, even if one single treatment plan is delivered during
the total course of radiotherapy, the uncertainties
described above make the data of the initial treatment
plan with doses to the target and OARs unreliable.
This study evaluates a DR algorithm to account for shrink-
age of NSCLC during primary radiochemotherapy. CT
images were acquired mid-way and at the end of the radi-
otherapy course and these CT images were registered with
the planning CT image. The DR algorithm requires (auto-
matic and manual) segmentation of all images and the
deformation map is based on corresponding surface
points. The accuracy of this DR approach was analyzed
and limitations were evaluated.
Materials and methods
This study is based on 13 patients treated with radiother-
apy (n = 1) or simultaneous radiochemotherapy (n = 12)
for primary, advanced stage NSCLC. Seven patients were
enrolled in a randomized phase III trial, where conven-
tionally fractionated radiotherapy was combined with
chemotherapy of cisplatin and oral vinorelbine; five addi-
tional patients were treated with the same radiotherapy
and chemotherapy protocol. Simultaneous chemotherapy
was refused by one patient, who was treated with radio-
therapy only. Written informed consent was obtained by
all patients. Details of patient and treatment characteris-
tics are listed in table 1.
For treatment planning, a conventional 3D CT study with
5 mm slice thickness was acquired for all patients using a
24-slice CT scanner (Somatom Sensation Open; Siemens
Medical Solutions, Erlangen, Germany). Midway through
treatment [median 21st day after start of treatment (19 -
24)] and in the sixth week of treatment [median 43rd day
after start of treatment (40 - 47)], a follow-up CT scan was
performed; patients were positioned in the same way as at
treatment planning and treatment delivery.
All CT images were imported into the Pinnacle treatment
planning system, research version 8.9 (Philips Radiation
Oncology Systems, Fitchburg, WI, USA). Images were reg-
istered using rigid automatic image registration in sixRadiation Oncology 2009, 4:68 http://www.ro-journal.com/content/4/1/68
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degrees of freedom with the region of interest for image
registration confined to the thoracic vertebral spine.
Lungs, spinal cord and the patients' outline were deline-
ated using automatic image segmentation. If the target
volumes were close to vertebral column (n = 11), the tra-
chea (n = 11), the aortic artery (n = 4) or the sternum (n =
1), these structures were additionally delineated using
semiautomatic segmentation: the structures were manu-
ally delineated in the planning CT series, then propagated
into the follow-up CT images and their shape and posi-
tion were adjusted automatically within the Pinnacle soft-
ware [11].
The macroscopic primary tumor was delineated as the
gross tumor volume (GTVprimary) in the CT pulmonary
window of the planning CT image; the soft tissue window
was used for delineation if the tumor was located adjacent
to the thoracic wall and to the mediastinum. Pathologi-
cally enlarged lymph nodes were included into this
GTVprimary if separation of the primary tumor and lymph
node metastases was not possible (n = 11). Lymph node
metastases were located distant to the primary tumors in
two patients and these lymph node metastases were delin-
eated as GTVLN. These GTV structures were propagated
into the follow-up CT images and the structures were
adjusted manually to account for changes of tumor posi-
tion, shape and size.
Deformable Image Registration
Prior to propagation and adaptation of the planning
structures in the follow-up CT images, all structures were
converted into 3D meshes: a mesh consists of vertices
located on the organ surface, connected by edges to neigh-
bouring triangles. These meshes were the basis for DR of
the primary planning CT image and all follow-up CT
images. In Pinnacle TPS a surface/model based DR is
implemented [12-15]: the deformation of a particular
location on the surface of one region of interest (ROI) is
measured from a vertex of the mesh in the reference data
set to the corresponding vertex in the secondary data set.
The set of all corresponding mesh vertices from all struc-
tures (control points of the deformation algorithm)
defines a surface deformation (Fig. 1). A deformation
model [elastic body splines (EBS), Gauss algorithm, Pois-
son's ratio of the elastic deformation (Nu) set to 0.3] then
interpolates the surface deformation to the entire volume
to derive a volumetric deformation field. The deformation
map was then applied to the follow-up CT image; in case
of a perfect DR, the deformed follow-up image should
then be identical to the planning CT image.
Table 1: Patient characteristics: squamous cell carcinoma (SSC), superior-inferior direction (SI), anterior-posterior direction (AP), 
cisplatin (DDP)
Patient Age 
(years)
Clinical 
T N stage
Stage Histology Motion 
amplitude in 
SI direction 
(mm)
GTV vol-
ume in 
planning CT 
(cm3)
Single 
dose (Gy)
Total 
dose (Gy)
Simultaneous 
chemotherapy
Pat #1 48,8 T4 N2 IIIB Adeno Ca < 5 42.2 2 66 DDP + 
Navelbine
Pat #2 52,6 T3 N3 IIIB Adeno Ca 12 60 2 66 DDP + 
Navelbine
Pat #3 71,5 T4 N2 IIIB SSC < 5 
(5 mm AP)
62.1 2 70 DDP + 
Navelbine
Pat #4 56,8 T3 N1 IIIA SSC 14 109.1 2 62 DDP + 
Navelbine
Pat #5 49,0 T2 N2 IIIA Adeno Ca 11 147.2 2 66 DDP + 
Navelbine
Pat #6 34,9 T4 N2 IIIB Adeno Ca < 5 160.1 2 70 DDP + 
Navelbine
Pat #7 74,2 T4 N2 IIIB Adeno Ca < 5 169.3 2 66 DDP + 
Navelbine
Pat #8 75,2 T4 N1 IIIA Adeno Ca < 5 202.9 2 66 DDP + 
Navelbine
Pat #9 61,7 T3 N2 IIIA Undifferentiated 
NSCLC
10 2 216.1 66 DDP + 
Navelbine
Pat #10 82,1 T4 N2 IIIB Adeno Ca < 5 225.2 2 66 none
Pat #11 57,6 T4 N3 IIIB Neuroendocrine 
Ca
< 5 302.8 2 66 DDP + 
Navelbine
Pat #12 63,5 T4 N3 IIIB Undifferentiated 
NSCLC
< 5 352.0 2 66 DDP + 
Navelbine
Pat #13 68,8 T2 N2 IIIA SSC < 5 382.5 2 70 DDP + 
NavelbineRadiation Oncology 2009, 4:68 http://www.ro-journal.com/content/4/1/68
Page 4 of 13
(page number not for citation purposes)
Follow-up CT images acquired mid-way through the radi-
otherapy series and at the end of radiotherapy were
deformed to the corresponding planning CT images.
Mesh points from GTV structures and all normal tissue
structures were selected for DR.
Evaluation of Deformable Image Registration
Visual evaluation of planning CT images (CTplan), follow-
up CT images (CTFU) and follow-up CT images deformed
to the planning CT image (CTdeform) was performed. CTp-
lan and CTFU were compared regarding the location of nor-
mal tissue landmark structures in the lung (small vessels
and bronchi) in relationship to the shrinking tumor. A
fixed position of these landmark structures in CTplan and
CTFU despite tumor shrinkage during radiotherapy would
suggest that the tumor had grown in an infiltrative pattern
within the pulmonary structure. A change of the position
of these landmark structures towards the shrinking tumor
in the CTFU would suggest an expansive, displacing growth
pattern.
Planning CT image and follow-up CT image acquired at week 6 of combined radiochemotherapy for patient #6: corresponding  three-dimensional meshes of the GTV, lungs, spinal cord and trachea are displayed in the second row Figure 1
Planning CT image and follow-up CT image acquired at week 6 of combined radiochemotherapy for patient 
#6: corresponding three-dimensional meshes of the GTV, lungs, spinal cord and trachea are displayed in the 
second row.
CT plan follow-up CT at 6 weeksRadiation Oncology 2009, 4:68 http://www.ro-journal.com/content/4/1/68
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For quantitative analysis of the DR, all images were
imported into in-house software. Two CT image series
were loaded into this software and manual registration of
these image data sets was performed with the registration
based on the bony spine. A cubic region of interest (ROI)
was defined for analysis of the differences between the
two image series. Two different ROIs were analyzed. ROI-
extended covered the GTV in superior-inferior direction plus
10 mm but included the whole body contour in axial
directions. ROIlimited covered the GTV plus 10 mm in all
directions. The Pearson's correlation coefficient (CC) was
calculated for corresponding voxels based on ROIextended
and ROIlimited and this was used as a parameter for the
similarity between the two image data sets.
Additionally, a landmark-based evaluation of the DR was
performed in the Pinnacle planning system. Correspond-
ing landmark structures were identified manually
between CTplan and CTFU and between CTplan and CTdeform
and the 3D distances between corresponding landmark
points were calculated; this analysis was limited to the
CTFU acquired in the sixth week of treatment. Four differ-
ent sets of anatomical landmarks were analyzed:
1. Most anterior, posterior, left, right, superior and
inferior position of the GTV
2. Carina
3. Bifurcations of intra-pulmonary vessels in the same
lobe as the NSCLC; analysis of four to five landmark
structures was intended
4. Bifurcations of intra-pulmonary vessels in the differ-
ent lobes compared to the NSCLC but in the same
lung; analysis of four to five landmark structures was
intended
Statistical analysis
Statistica 7.0 was utilized for statistical analysis (Statsoft,
Tulsa, OK, USA). Mann-Whitney-U test was performed for
comparison of two subset analyses and Wilcoxon test was
used for matched pair analyses. The differences were con-
sidered significant for p < 0.05.
Results
Quantification of tumor regression
Median volume of the GTV in the planning CT images was
170 cm3 (range 25 cm3 - 353 cm3); the GTV volume
decreased to median 124 cm3 (19 cm3 - 325 cm3) and 100
cm3 (10 cm3 - 270 cm3) mid-way and at the end of radio-
chemotherapy.
Comparison of CTplan and CTFU was performed for quan-
tification of anatomical changes during the treatment
course. Based on ROIextended, CC was 0.76 ± 0.11 and 0.74
± 0.10 for comparison of CTplan and the CTFU acquired
mid-way and at the end of treatment, respectively (Fig. 2).
If the analysis was based on ROIlimited, CC was decreased
with 0.64 ± 0.15 and 0.53 ± 0.16 mid-way and at the end
of treatment, respectively (Fig. 3). These values indicate
progressive changes of the patients' anatomy and GTV vol-
ume and shape during treatment.
For ROIlimited, absolute reduction of the GTV volume
between CTplan and CTFU at the end of treatment was sig-
nificantly correlated with the CC between CTplan and CTFU
(p = 0.05): increased tumor shrinkage resulted in lower
CC values. This correlation was not significant for differ-
ences between CTplan and CTFU acquired midway of the
treatment (p = 0.15).
Morphological pattern of tumor regression
Visual evaluation of CTplan and CTFU acquired at the end of
the treatment course regarding normal tissue landmark
structures in the lung located close to the tumor showed
inconsistent results. No suitable landmark structures were
found in two patients. A morphological pattern of tumor
shrinkage, where the pulmonary tissue expanded due to
tumor shrinkage during the treatment course was
observed in two patients; both tumors were located cen-
trally (Fig. 4a). A pattern of tumor shrinkage, where the
pulmonary tumor released vessels and bronchi during the
treatment course was observed in four patients (Fig. 4b).
A mixed regression pattern was observed in 5/13 patients.
Visual evaluation of deformable image registration
CTplan and CTFU were not acquired with respiration corre-
lated 4D-CT imaging and consequently were not captured
in corresponding phases of breathing. This was corrected
successfully by DR indicated by a close match of the dia-
phragm, chest wall and mediastinum. Also weight loss
was corrected by DR indicated by a close match of the
patients' outline; note that the patient's outline was used
for calculation of the deformation map. Severe deforma-
tion artefacts were observed in three patients: a large pleu-
ral effusion resolved completely in two patients and a
large atelectasis resolved in another patient. The shape of
the target in the deformed image was affected in the
patient with the resolved atelectasis.
Regarding the shape of the GTV, best visual results of the
DR were observed in patients with large, solid tumors,
which were clearly separated from the surrounding nor-
mal tissue in both CTplan and CTFU. Two examples of accu-
rate DR are shown in fig. 5 and 6. Three situations caused
significant deformation artefacts. In one patient, a resolv-
ing atelectasis could not be covered by segmentation and
DR (described above). In one patient, the tumor was
located around large bronchi and segmentation of theseRadiation Oncology 2009, 4:68 http://www.ro-journal.com/content/4/1/68
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bronchi as normal tissue was not possible, because the
structures were too small (Fig. 7, patient # 5). In the last
case, no clear shrinkage but more a decay of the tumor was
observed during the treatment course (Fig. 7, patient # 4).
The pulmonary tissue in close vicinity around the tumor
showed moderate to severe deformation artefacts in all
patients: application of the deformation matrix to CTFU
expanded the GTV to the initial size in CTplan with the con-
sequence of "compression" of the surrounding pulmo-
nary tissue.
Quantitative evaluation of deformable image registration
Comparison of CTplan and CTdeform was performed for
evaluation of the DR. Based on ROIextended, DR improved
the CC for images acquired mid-way of the treatment
course from 0.76 ± 0.11 to 0.88 ± 0.03. For CT images
acquired at the end of treatment, a similar improvement
was observed: CC increased from 0.74 ± 0.10 to 0.86 ±
0.05. Improvements in these CC values were observed for
all 13 patients. Detailed results are shown in fig. 2.
If ROIlimited  was used for evaluation of the DR, the
improvement in the similarity values was smaller com-
pared to ROIextended. For images acquired mid-way of the
treatment, DR improved CC from 0.64 ± 0.15 to 0.70 ±
0.15. However, similarity decreased for 2/13 patients.
Similar findings were made for images acquired at the end
of treatment: DR improved CC from 0.53 ± 0.16 to 0.62 ±
0.14. Decreased similarity was observed for 3/13 patients.
Detailed results are shown in fig. 3.
Patient individual voxel-based analysis of deformable image registration based on ROIextended (covering the GTV + 10 mm in  superior-inferior direction but including the whole body contour in axial directions) Figure 2
Patient individual voxel-based analysis of deformable image registration based on ROIextended (covering the 
GTV + 10 mm in superior-inferior direction but including the whole body contour in axial directions). Correla-
tion-coefficients (CC) were calculated between the planning CT image and original/deformed follow-up CT image (mid-way 
and at the end of the treatment course).Radiation Oncology 2009, 4:68 http://www.ro-journal.com/content/4/1/68
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The ratio r = CC (CTplan vs. CTdeform)/CC (CTplan vs. CTFU)
for ROIlimited was significantly correlated with the volume
of the GTV in CTplan (p = 0.03): an increased improvement
in similarity due to DR was observed for larger GTV vol-
umes. Additionally, a significant correlation between
changes of the CC due to DR and absolute volume reduc-
tion of the GTV was observed (p = 0.02): improvement in
similarity due to DR was larger for increased tumor
shrinkage.
Manual landmark registration for evaluation of the accu-
racy of the DR was performed. Distances (3D vector)
between corresponding landmark points on the GTV sur-
face were 11.8 mm ± 5.1 mm for CTplan versus CTFU and
these distances were reduced to 2.9 mm ± 1.2 mm for CTp-
lan versus CTFU after DR was performed. However, in two
patients the performance of the DR was not sufficient for
reliable analysis of the GTV shape in CTdeform and these
two patients were excluded from the analysis above.
Regarding the carina and vessel bifurcations, DR reduced
the distances between corresponding landmark structures
by about 40% on average; residual errors after DR ranged
between 4 mm and 6 mm on average; detailed results are
shown in table 2.
In general, good agreement between visual and quantita-
tive analysis of DR was observed. However, poor CC val-
ues were observed in two patients despite good visual
results regarding the shape of the GTV: an air-filled cavern
developed within the GTV during radiochemotherapy in
these two patients; DR successfully restore the GTV out-
line in these two patients but the inside of the GTV was
soft-tissue in CTplan and partially air in CTdeform resulting
in poor CC.
Patient individual voxel-based analysis of deformable image registration based on ROIlimited (covering the GTV plus 10 mm in all  directions) Figure 3
Patient individual voxel-based analysis of deformable image registration based on ROIlimited (covering the GTV 
plus 10 mm in all directions). Correlation-coefficients (CC) were calculated between the planning CT image and original/
deformed follow-up CT image (mid-way and at the end of the treatment course).Radiation Oncology 2009, 4:68 http://www.ro-journal.com/content/4/1/68
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Discussion
The performance of different DR algorithms has been val-
idated based on respiration correlated CT images in the
thoracic region by a number of studies [15-24]. However,
deformable image registration for advanced stage NSCLC
with repeated CT images during the course of treatment is
significantly more difficult for DR: regression of the tumor
volume combined with weight loss of the patients and
changes of atelectasis and pleural effusions make DR espe-
cially challenging. To our best knowledge, this is the first
study evaluating the accuracy of DR in the context of such
dramatic anatomical changes.
CT images acquired midway of the radiochemotherapy
showed a decrease of the median GTV volume by almost
30% and the median GTV volume was reduced by more
than 40% in CT images acquired at the end of treatment.
This significant tumor regression is in good agreement
with data in the literature [9,25-27]. In contrast, Bosmans
et al. reported no decrease of the tumor volume in CT
images acquired in the first and second week of radiother-
apy on average for 23 patients, but a large heterogeneity
was observed in this patient population [28]; similar find-
ings were made for metastatic lymph nodes [29]. Clini-
cally significant tumor regression was not observed by
Siker et al, however, hypo-fractionated irradiation sche-
mas were used in that study [30].
Overall, the surface-based algorithm of DR performed rea-
sonable with large differences between patients. As
expected, results of the DR were better for registration of
the planning CT and CT images acquired mid-way of
treatment compared to registration of planning CT and
CT images acquired at the end of the treatment course.
Differences between planning CT and follow-up CT
images caused by patients' weight loss and different
Morphological patter of tumor shrinkage for Figure 4
Morphological patter of tumor shrinkage fora) patient # 11: the tumor surrounding pulmonary tissue expanded in cor-
relation with shrinkage of the tumor, b) patient # 5: tumor shrinkage released the pulmonary structures (bronchi and ves-
sels). The contour of the macroscopic primary tumor is shown in red and arrows point to pulmonary landmark structures 
surrounding the tumor.
CT plan
CT end of treatment
CT plan
CT end of treatment
ABRadiation Oncology 2009, 4:68 http://www.ro-journal.com/content/4/1/68
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Patient # 12: a) planning CT; b) follow-up CT at the end of treatment; c) difference image between planning CT and follow-up  CT; d) deformed follow-up CT using all target and organs-at risk meshes; e) deformed follow-up CT using target, lung and spi- nal cord; f) difference image between planning CT and deformed follow-up CT based on all target organs-at risk meshes Figure 5
Patient # 12: a) planning CT; b) follow-up CT at the end of treatment; c) difference image between planning 
CT and follow-up CT; d) deformed follow-up CT using all target and organs-at risk meshes; e) deformed fol-
low-up CT using target, lung and spinal cord; f) difference image between planning CT and deformed follow-up 
CT based on all target organs-at risk meshes. The contours of the macroscopic primary tumor in the planning CT and 
the follow-up CT are shown in red. Note the distortion of the vertebral body and the aorta without using meshes of these 
organs for deformable registration in e).
ac b
d f e
Patient # 6: a) planning CT; b) follow-up CT at the end of treatment; c) difference image between planning CT and follow-up  CT; d) deformed follow-up CT using all target and organs-at risk meshes; e) deformed follow-up CT using target, lung and spi- nal cord; f) difference image between planning CT and deformed follow-up CT based on all target organs-at risk meshes Figure 6
Patient # 6: a) planning CT; b) follow-up CT at the end of treatment; c) difference image between planning CT 
and follow-up CT; d) deformed follow-up CT using all target and organs-at risk meshes; e) deformed follow-up 
CT using target, lung and spinal cord; f) difference image between planning CT and deformed follow-up CT 
based on all target organs-at risk meshes. The contours of the macroscopic primary tumor in the planning CT and the 
follow-up CT are shown in red. Note the distortion of the vertebral body and the trachea without using meshes of these 
organs for deformable registration in e).
d f e
ac bRadiation Oncology 2009, 4:68 http://www.ro-journal.com/content/4/1/68
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phases of breathing were managed well by the DR in all
patients indicated by a close match of the mediastinum,
chest wall, diaphragm and outline.
Manual landmark registration was performed for evalua-
tion of the DR accuracy. Residual errors after DR were
small at the GTV surface with 3D errors of 2.9 mm on
average. Larger residual errors after DR were measured for
intrapulmonary vessel bifurcations and the carina, where
3D errors ranged between 4.5 mm and 6.3 mm on aver-
age. These residual errors after DR are slightly larger com-
pared to studies using surface-based DR in respiration
correlated CT images [15,16]. However, results are realis-
tic considering the tremendous anatomical changes
observed in our study compared to the moderate anatom-
ical changes usually observed in respiration correlated CT
images. Studies using different DR algorithms for respira-
tion correlated CT images reported residual errors of land-
mark registration ranging between 1 mm and 5 mm on
average depending on the DR algorithm and type of land-
mark structures [17,18,20-22].
The surface-based DR algorithm has been validated on
respiration correlated CT images of patients with pulmo-
nary tumors and it has been described that segmentation
of the GTV, lung, heart and spinal cord are sufficient for
Suboptimal results of deformable image registration Figure 7
Suboptimal results of deformable image registration. The contours of the macroscopic primary tumor in the planning 
CT and the follow-up CT are shown in red and arrows point to artefacts after deformable image registration. Patient #5: 
deformation artefacts of the hilar bronchi (which were included into the GTV). The rather large amount of normal tissue 
within the GTV is probably responsible for this poor performance of DR. Patient #4: deformation artefacts after tumor shrink-
age with a decay of the GTV.
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Table 2: Results of manual landmark registration for evaluation of the accuracy of the deformable image registration
CTplan versus CTFU CTplan versus CTdeform
Average (mm) StDev (mm) 90th percentile 
(mm)
Average (mm) StDev (mm) 90th percentile (mm)
GTV 11.8 ± 5.1 21 2.9 ± 1.2 5.7
Carina 6.0 ± 3.2 10 4.5 ± 2.5 6.5
Pulmonary landmarks - 
same lobe as GTV
8.3 ± 3.8 15 5.5 ± 2.3 11
Pulmonary landmarks - 
different lobes as GTV
8.0 ± 3.8 13 6.3 ± 2.8 13Radiation Oncology 2009, 4:68 http://www.ro-journal.com/content/4/1/68
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generation of the deformation map [31]. Our results sug-
gest that more normal structures need to be segmented in
adaptive radiotherapy during conventionally fractionated
radiotherapy. The outline is certainly necessary to deal
with weight loss of the patients. Additionally, segmenta-
tion of normal structures in close vicinity to the shrinking
tumor was performed (vertebral bodies, trachea, aortic
arch, sternum); otherwise the DR resulted in distortion of
these normal structures. The effort for segmentation of
these normal structures is acceptable because definition of
organ models for automatic segmentation is straight for-
ward.
For DR of the GTV itself, three situations are considered to
be most problematic. First, for central tumors infiltrating
the hilar and mediastinal structures, separate segmenta-
tion of tumor versus bronchi and vessels was not possible
in all patients and these OARs were included into the
GTV. This was done because the OARs were too small for
manual and automatic segmentation or because separa-
tion of GTV and OARs was not possible in CT images
without application of i.v. contrast or additional biologi-
cal imaging. Consequences were deformation artefacts of
these OARs after application of DR.
Second, a decay of the tumor with dissolving boundaries
between tumor and lung is difficult for all methods of DR.
Such a response pattern was observed in one of the
patients. Reports in the literature mainly focused on volu-
metric analysis and did not describe such morphological
changes of tumor regression. Adaptive approaches with
shrinking irradiation fields are certainly not safe in these
patients.
Third, a pattern of tumor regression with the pulmonary
frame remaining stable was impossible to solve for the
DR. This is illustrated in fig. 8. The tumor is growing in an
infiltrative pattern within the pulmonary frame. During
radiochemotherapy tumor regression occurs with the
position of the pulmonary frame remaining stable. The
algorithm of DR then expands the tumor to the original
size and shape and the consequences are deformation
artefacts with compression of the pulmonary tissue. Such
a pattern of tumor shrinkage was observed at least par-
tially in 9/13 patients. To cope with this issue, DR algo-
rithms needed to know that one voxel can belong to two
different organs with different corresponding deforma-
tion vectors.
Major disadvantage of this surface based DR method is the
need for segmentation of all images. Auto-segmentation
worked reasonable well for the OARs, however, manual
delineation of the pulmonary tumor was required. All
delineation work was performed by one single observer
(MG) because large inter-observer variability in delinea-
tion of pulmonary tumors is a well known issue even if
standardised protocols are defined [32,33]. Additionally,
FDG-PET images were integrated into target definition,
which has been shown to reduce delineation uncertainties
significantly [34,35]. No method of GTV auto-contouring
was applied because FDG-PET images were only available
for treatment planning and because there still exist uncer-
Illustration of the consequences of an infiltrative growth pattern on deformable image registration: left image) infiltrative  growth pattern of the NSCLC (yellow with mesh points on the surface); middle image) tumor regression (red with mesh  points on the surface) with release of the pulmonary structures; right image) transformation of the middle image into the left  image based on the mesh points on the surface of the GTV: note the distortion of the pulmonary structures Figure 8
Illustration of the consequences of an infiltrative growth pattern on deformable image registration: left image) 
infiltrative growth pattern of the NSCLC (yellow with mesh points on the surface); middle image) tumor regression (red with 
mesh points on the surface) with release of the pulmonary structures; right image) transformation of the middle image into the 
left image based on the mesh points on the surface of the GTV: note the distortion of the pulmonary structures.
Planning image Follow-up image Deformed 
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tainties about the best method for FDG-PET based auto-
segmentation of lung tumors [36-38].
Some limitations of this study need to be addressed. 1) As
discussed above, manual segmentation of the tumor was
performed with the consequence of potential intra-
observer variability. 2) CT images were acquired without
application of 4D respiration correlated technique; this
was done to limit radiation exposure of the patient by
repeated CT imaging. However, this is not considered to
influence results significantly. A 4D-CT was acquired at
treatment planning for all patients and motion amplitude
was ≤10 mm in 10 patients and maximum 14 mm. Con-
sequently, motion artefacts due to free breathing during
image acquisition are considered to be small using a 24-
slice CT scanner. 3) Elastic body splines were used by the
DR algorithm for interpolation within the organs. It has
been shown that the application of algorithms based on
appropriate tissue parameters improves the accuracy of
this interpolation process [39]. However, exact parame-
ters for all normal tissues are not available and it is
unknown whether these parameters need to be patient-
specific or not. 4) Macroscopic tumors are well known to
be composed of subvolumes with different biological
behaviour e.g. perfusion, hypoxia and proliferation. Con-
sequently, homogeneous tumor shrinkage during radio-
chemotherapy is highly unlikely. However, this was not
considered by the surface based DR in our study. Voxel-
based DR algorithms would also not have been able to
deal with this issue because biological characterization is
not possible in CT images. Repeated biological imaging
during radiotherapy and radiochemotherapy will be
required for further analysis of this important aspect of
adaptive radiotherapy.
We have recently established dose calculation in cone-
beam CT images [40] and it is planned to use these cone-
beam CT images in the process of adaptive radiotherapy.
Consequently, DR between spiral CT images and cone-
beam CT images needs to be analyzed as the next step.
Conclusions
The surface-based DR performed accurately for the major-
ity of the patients with locally advanced NSCLC and is
considered as suitable for application in adaptive radio-
therapy. Residual errors after DR were small at the surface
of the GTV, but larger uncertainties within the lungs need
to be considered.
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